Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

per Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Minisini, Alessandro Marco, Rihawi, Karim, Fasola, Gianpiero, Puglisi, Fabio
Publicat a Oncologist (2015)

Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors

per Garutti, Mattia, Pelizzari, Giacomo, Bartoletti, Michele, Malfatti, Matilde Clarissa, Gerratana, Lorenzo, Tell, Gianluca, Puglisi, Fabio
Publicat a Int J Mol Sci (2019)

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

per Gerratana, Lorenzo, De Maglio, Giovanna, De Pellegrin, Alessandro, Follador, Alessandro, Rihawi, Karim, Pizzolitto, Stefano, Puglisi, Fabio, Fasola, Gianpiero
Publicat a Onco Targets Ther (2016)

Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach

per Cortiula, Francesco, De Maglio, Giovanna, Cangi, Maria Giulia, Gerratana, Lorenzo, Lisanti, Camilla, Bonura, Salvatore, Fasola, Gianpiero, Follador, Alessandro
Publicat a Ann Transl Med (2019)

APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC

per Malfatti, Matilde Clarissa, Gerratana, Lorenzo, Dalla, Emiliano, Isola, Miriam, Damante, Giuseppe, Di Loreto, Carla, Puglisi, Fabio, Tell, Gianluca
Publicat a J Exp Clin Cancer Res (2019)

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

per Bartoletti, Michele, Pelizzari, Giacomo, Gerratana, Lorenzo, Bortot, Lucia, Lombardi, Davide, Nicoloso, Milena, Scalone, Simona, Giorda, Giorgio, Baldassarre, Gustavo, Sorio, Roberto, Puglisi, Fabio
Publicat a Int J Mol Sci (2020)

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

per Bonotto, Marta, Gerratana, Lorenzo, Poletto, Elena, Driol, Pamela, Giangreco, Manuela, Russo, Stefania, Minisini, Alessandro M., Andreetta, Claudia, Mansutti, Mauro, Pisa, Federica E., Fasola, Gianpiero, Puglisi, Fabio
Publicat 2014

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

per Davis, Andrew A., Zhang, Qiang, Gerratana, Lorenzo, Shah, Ami N., Zhan, Youbin, Qiang, Wenan, Finkelman, Brian S., Flaum, Lisa, Behdad, Amir, Gradishar, William J., Platanias, Leonidas C., Cristofanilli, Massimo
Publicat a Breast Cancer Res (2019)

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside

per Basile, Debora, Di Nardo, Paola, Corvaja, Carla, Garattini, Silvio Ken, Pelizzari, Giacomo, Lisanti, Camilla, Bortot, Lucia, Da Ros, Lucia, Bartoletti, Michele, Borghi, Matteo, Gerratana, Lorenzo, Lombardi, Davide, Puglisi, Fabio
Publicat a Cancers (Basel) (2019)

Landscape of circulating tumour DNA in metastatic breast cancer

per Davis, Andrew A., Jacob, Saya, Gerratana, Lorenzo, Shah, Ami N., Wehbe, Firas, Katam, Neelima, Zhang, Qiang, Flaum, Lisa, Siziopikou, Kalliopi P., Platanias, Leonidas C., Gradishar, William J., Behdad, Amir, Cristofanilli, Massimo
Publicat a EBioMedicine (2020)

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

per Bulfoni, Michela, Gerratana, Lorenzo, Del Ben, Fabio, Marzinotto, Stefania, Sorrentino, Marisa, Turetta, Matteo, Scoles, Giacinto, Toffoletto, Barbara, Isola, Miriam, Beltrami, Carlo Alberto, Di Loreto, Carla, Beltrami, Antonio Paolo, Puglisi, Fabio, Cesselli, Daniela
Publicat a Breast Cancer Res (2016)

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer

per Basile, Debora, Gerratana, Lorenzo, Buonadonna, Angela, Garattini, Silvio Ken, Perin, Tiziana, Grassilli, Emanuela, Miolo, Gianmaria, Cerrito, Maria Grazia, Belluco, Claudio, Bertola, Giulio, De Paoli, Antonino, Cannizzaro, Renato, Lavitrano, Marialuisa, Puglisi, Fabio, Canzonieri, Vincenzo
Publicat a Cancers (Basel) (2019)

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

per Cinausero, Marika, Laprovitera, Noemi, De Maglio, Giovanna, Gerratana, Lorenzo, Riefolo, Mattia, Macerelli, Marianna, Fiorentino, Michelangelo, Porcellini, Elisa, Buoro, Vanessa, Gelsomino, Francesco, Squadrilli, Anna, Fasola, Gianpiero, Negrini, Massimo, Tiseo, Marcello, Ferracin, Manuela, Ardizzoni, Andrea
Publicat a Ther Adv Med Oncol (2019)

Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis

per De Angelis, Carmine, Di Maio, Massimo, Crispo, Anna, Giuliano, Mario, Schettini, Francesco, Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Cinausero, Marika, Riccardi, Ferdinando, Ciancia, Giuseppe, De Laurentiis, Michelino, Puglisi, Fabio, De Placido, Sabino, Arpino, Grazia
Publicat a Oncotarget (2017)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

per Gerratana, Lorenzo, Basile, Debora, Franzoni, Alessandra, Allegri, Lorenzo, Viotto, Davide, Corvaja, Carla, Bortot, Lucia, Bertoli, Elisa, Buriolla, Silvia, Targato, Giada, Da Ros, Lucia, Russo, Stefania, Bonotto, Marta, Belletti, Barbara, Baldassarre, Gustavo, Damante, Giuseppe, Puglisi, Fabio
Publicat a Front Oncol (2020)

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer

per Reduzzi, Carolina, Di Cosimo, Serena, Gerratana, Lorenzo, Motta, Rosita, Martinetti, Antonia, Vingiani, Andrea, D’Amico, Paolo, Zhang, Youbin, Vismara, Marta, Depretto, Catherine, Scaperrotta, Gianfranco, Folli, Secondo, Pruneri, Giancarlo, Cristofanilli, Massimo, Daidone, Maria Grazia, Cappelletti, Vera
Publicat a Cancers (Basel) (2021)

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker

per Pelizzari, Giacomo, Basile, Debora, Zago, Silvia, Lisanti, Camilla, Bartoletti, Michele, Bortot, Lucia, Vitale, Maria Grazia, Fanotto, Valentina, Barban, Serena, Cinausero, Marika, Bonotto, Marta, Gerratana, Lorenzo, Mansutti, Mauro, Curcio, Francesco, Fasola, Gianpiero, Minisini, Alessandro Marco, Puglisi, Fabio
Publicat a Cancers (Basel) (2019)

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

per Basile, Debora, Gerratana, Lorenzo, Corvaja, Carla, Pelizzari, Giacomo, Franceschin, Giorgia, Bertoli, Elisa, Palmero, Lorenza, Zara, Diego, Alberti, Martina, Buriolla, Silvia, Da Ros, Lucia, Bonotto, Marta, Mansutti, Mauro, Spazzapan, Simon, Cinausero, Marika, Minisini, Alessandro Marco, Fasola, Gianpiero, Puglisi, Fabio
Publicat a Breast (2021)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer

per Gerratana, Lorenzo, Davis, Andrew A., Zhang, Qiang, Basile, Debora, Rossi, Giovanna, Strickland, Kimberly, Franzoni, Alessandra, Allegri, Lorenzo, Mu, Zhaomei, Zhang, Youbin, Flaum, Lisa E., Damante, Giuseppe, Gradishar, William John, Platanias, Leonidas C., Behdad, Amir, Yang, Hushan, Puglisi, Fabio, Cristofanilli, Massimo
Publicat a JCO Precis Oncol (2021)

The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte‐to‐Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer

per Basile, Debora, Garattini, Silvio Ken, Corvaja, Carla, Montico, Marcella, Cortiula, Francesco, Pelizzari, Giacomo, Gerratana, Lorenzo, Audisio, Marco, Lisanti, Camilla, Fanotto, Valentina, Ongaro, Elena, Iacono, Donatella, Cardellino, Giovanni Gerardo, Foltran, Luisa, Pella, Nicoletta, Buonadonna, Angela, Aprile, Giuseppe, Di Maio, Massimo, Fasola, Gianpiero, Puglisi, Fabio
Publicat a Oncologist (2020)